The Reporting of Harms in Randomized Controlled Trials of Hypertension Using the CONSORT Criteria for Harm Reporting

Author： Bagul Nitin Babulal Kirkham Jamie J.

ISSN： 1064-1963

Source： Clinical and Experimental Hypertension, Vol.34, Iss.8, 2012-12, pp. : 548-554

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Evidence of improving quality of reporting of randomized controlled trials in subfertility

By Dias Sofia McNamee Roseanne Vail Andy

Human Reproduction, Vol. 21, Iss. 10, 2006-10 ,pp. : 2617-2627

Oxford University Press

Access to resources Recommend Favorite

Underpowering in randomized trials reporting a sample size calculation

By Vickers A.J.

Journal of Clinical Epidemiology, Vol. 56, Iss. 8, 2003-08 ,pp. : 717-720

Elsevier

Access to resources Recommend Favorite

Ginseng for Treating Hypertension: A Systematic Review and Meta-Analysis of Double Blind, Randomized, Placebo-Controlled Trials

Current Vascular Pharmacology, Vol. 15, Iss. 6, 2017-09 ,pp. : 549-556

Bentham Science Publishers

Access to resources Recommend Favorite

Outcome Reporting in Cardiac Surgery Trials: Systematic Review and Critical Appraisal

JOURNAL OF THE AMERICAN HEART ASSOCIATION, Vol. 4, Iss. 8, 2015-08 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Asthma research and randomized controlled trials: a remarkable phenomenon

By Hafkamp-de Groen Esther Raat Hein

Journal of Asthma, Vol. 47, Iss. 9, 2010-11 ,pp. : 1063-1064

Informa Healthcare

Access to resources Recommend Favorite